Your session is about to expire
← Back to Search
Behavioral Intervention
Culturally Relevant Supportive Care for Advanced Cancer
N/A
Recruiting
Led By Dalnim Cho, PhD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year.
Awards & highlights
Study Summary
This trial aims to determine if a culturally adapted mind-body intervention can help Black patients w/advanced cancer. Formative research will be conducted & an intervention format will be determined. A pilot RCT will compare this intervention vs. a psychoeducation intervention.
Who is the study for?
This trial is for Black/African American individuals aged 18 or older with stage III-IV solid tumors, on active treatment, and have a performance status allowing daily activity. They must be able to consent and have internet access. If the program is family-based, they need a caregiver living with them who can also participate.Check my eligibility
What is being tested?
The study tests a culturally adapted mind-body intervention called MBS-A designed for Black patients with advanced cancer. It involves surveys, interviews, meditation exercises, and possibly group sessions to see if it's feasible as supportive care compared to standard psychoeducation.See study design
What are the potential side effects?
Since this trial focuses on meditation exercises and interviews rather than medication or invasive procedures, significant side effects are not anticipated. However, participants may experience emotional discomfort discussing their condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion; an average of 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
MD Anderson Symptom Inventory-Score Scale
Trial Design
3Treatment groups
Experimental Treatment
Group I: Aim 3 (supportive care program)Experimental Treatment2 Interventions
Participants will be assessed regarding their program participation
Group II: Aim 2 (supportive care program)Experimental Treatment2 Interventions
Participants will be assigned to one of two groups
Group III: Aim 1 (individual interview)Experimental Treatment2 Interventions
Participants will be interviewed
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Individual Interview
2018
N/A
~30
Find a Location
Who is running the clinical trial?
National Center for Complementary and Integrative Health (NCCIH)NIH
832 Previous Clinical Trials
668,933 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
2,973 Previous Clinical Trials
1,789,306 Total Patients Enrolled
Dalnim Cho, PhDPrincipal InvestigatorM.D. Anderson Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 or older, identify as Black/African American, and have a late-stage solid tumor.I am Black/African American, 18+, with stage III-IV solid tumor, on treatment, can move around, have internet, and can consent.I live with a family member who can care for me.I am over 18, can access the internet, and can consent to participate.
Research Study Groups:
This trial has the following groups:- Group 1: Aim 3 (supportive care program)
- Group 2: Aim 2 (supportive care program)
- Group 3: Aim 1 (individual interview)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is registration for this trial open presently?
"This clinical trial, which was posted on August 31st 2023 and last modified on February 28th 2023 is not currently enrolling patients. However, there are 507 other studies that are open for recruitment at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger